³Ô¹ÏÍøÕ¾

Latest therapeutics News | Page 6

‘Introspective’ AI Finds Diversity Improves Performance
Nanoneedle breakthrough gives hope for cheaper cancer treatment
Nominations open for AusBiotech Board 22 August
Pill could provide alternative to weight loss surgery
A prescription product to help people at risk of dying by suicide
Fast Five with Jonathan Lozano-Salgado
Can the body’s signalling protein be harnessed to stop ovarian cancer?
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Monash University and Moderna form partnership to advance homegrown mRNA medicines
Potential neuropathic pain treatment shows promise in preclinical tests
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
Universal siRNA Covid treatment shows promise in lab
Landmark public health decisions by WHO on essential medicines for alcohol use disorders
Researchers investigate new therapy to heal osteoporosis fractures
Scientists push boundaries in flu fight
New AusBiotech report shows increasing US investment in Australian biotechs
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Chimeric receives patent allowance for chlorotoxin in Japan
100 Future Fellows Awarded Funding
Improving health outcomes for people living with post-acute sequelae of COVID-19 (long COVID)
Promising new drug to manage high blood pressure
BioCurate in new partnership with the European Healthtech Venture Builder
Nonsense and quality control wins $US500,000
World first trial for kids with Duchenne Muscular Dystrophy
NSW new world first trial for kids with Duchenne Muscular Dystrophy
Restoring Lost Sense of Smell
Early-Stage Innovation Forum opens
New anti-inflammatory drug – one medicine to rule them all
RNA – changing face of modern medicine
Cynata Therapeutics announces CEO succession and board changes
Takeda’s COCKPI-T programme calls for applications
University spinout signs agreement on Alzheimer’s disease biomarkers
NSW new first look at Australia’s first purpose-built Biocontainment Centre
New venom discovery from deadly cone snails
The Oligonucleotide Therapeutics Society is Pleased to Announce the 2023 Annual Meeting in Barcelona, Spain
Researchers develop a new approach to scale-up manufacturing of life-saving oligonucleotide therapeutics
Top performing ASX life science companies
Infectious Disease Institute Now Step Closer
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Medicinal cannabis is a ‘life-changing treatment’ for people with Tourette syndrome
Stakeholders meet in WHO to review progress towards elimination of human African trypanosomiasis
New Monash Spinout Resseptor Therapeutics Launches With AU$2.25M Investment From IP Group
University of Enterprise on mission to expand biotech partnerships
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Zelira Therapeutics announces the appointment of new non-executive director
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma